annual net income:
$341.30M+$91.60M(+36.68%)Summary
- As of today (April 18, 2025), NBIX annual net profit is $341.30 million, with the most recent change of +$91.60 million (+36.68%) on December 1, 2024.
- During the last 3 years, NBIX annual net income has risen by +$251.70 million (+280.92%).
- NBIX annual net income is now -16.20% below its all-time high of $407.30 million, reached on December 31, 2020.
Performance
NBIX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$103.10M-$26.70M(-20.57%)Summary
- As of today (April 18, 2025), NBIX quarterly net profit is $103.10 million, with the most recent change of -$26.70 million (-20.57%) on December 1, 2024.
- Over the past year, NBIX quarterly net income has increased by +$59.70 million (+137.56%).
- NBIX quarterly net income is now -70.37% below its all-time high of $347.90 million, reached on December 31, 2020.
Performance
NBIX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$341.30M-$44.60M(-11.56%)Summary
- As of today (April 18, 2025), NBIX TTM net profit is $341.30 million, with the most recent change of -$44.60 million (-11.56%) on December 1, 2024.
- Over the past year, NBIX TTM net income has dropped by -$28.40 million (-7.68%).
- NBIX TTM net income is now -23.27% below its all-time high of $444.80 million, reached on September 30, 2021.
Performance
NBIX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
NBIX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.7% | +137.6% | -7.7% |
| 3 y3 years | +280.9% | +137.6% | -7.7% |
| 5 y5 years | +822.4% | +137.6% | -7.7% |
NBIX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +280.9% | -30.2% | +234.6% | -11.6% | +2697.5% |
| 5 y | 5-year | -16.2% | +822.4% | -70.4% | +234.6% | -23.3% | +2697.5% |
| alltime | all time | -16.2% | +264.6% | -70.4% | +180.6% | -23.3% | +255.2% |
Neurocrine Biosciences Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $341.30M(+36.7%) | $103.10M(-20.6%) | $341.30M(-11.6%) |
| Sep 2024 | - | $129.80M(+99.7%) | $385.90M(+13.8%) |
| Jun 2024 | - | $65.00M(+49.8%) | $339.20M(-8.2%) |
| Mar 2024 | - | $43.40M(-70.6%) | $369.70M(+48.1%) |
| Dec 2023 | $249.70M(+61.6%) | $147.70M(+77.7%) | $249.70M(+30.7%) |
| Sep 2023 | - | $83.10M(-13.0%) | $191.00M(+8.3%) |
| Jun 2023 | - | $95.50M(-224.7%) | $176.40M(+175.6%) |
| Mar 2023 | - | -$76.60M(-186.1%) | $64.00M(-58.6%) |
| Dec 2022 | $154.50M(+72.4%) | $89.00M(+29.9%) | $154.50M(+165.5%) |
| Sep 2022 | - | $68.50M(-505.3%) | $58.20M(+377.0%) |
| Jun 2022 | - | -$16.90M(-221.6%) | $12.20M(-82.9%) |
| Mar 2022 | - | $13.90M(-290.4%) | $71.40M(-20.3%) |
| Dec 2021 | $89.60M(-78.0%) | -$7.30M(-132.4%) | $89.60M(-79.9%) |
| Sep 2021 | - | $22.50M(-46.8%) | $444.80M(+22.0%) |
| Jun 2021 | - | $42.30M(+31.8%) | $364.70M(-9.3%) |
| Mar 2021 | - | $32.10M(-90.8%) | $402.00M(-1.3%) |
| Dec 2020 | $407.30M(+1000.8%) | $347.90M(-704.0%) | $407.30M(+336.1%) |
| Sep 2020 | - | -$57.60M(-172.4%) | $93.40M(-54.4%) |
| Jun 2020 | - | $79.60M(+112.8%) | $204.80M(+16.0%) |
| Mar 2020 | - | $37.40M(+10.0%) | $176.50M(+377.0%) |
| Dec 2019 | $37.00M(+75.4%) | $34.00M(-36.8%) | $37.00M(+75.6%) |
| Sep 2019 | - | $53.80M(+4.9%) | $21.07M(+16.8%) |
| Jun 2019 | - | $51.30M(-150.2%) | $18.03M(-146.0%) |
| Mar 2019 | - | -$102.10M(-665.1%) | -$39.18M(-285.7%) |
| Dec 2018 | $21.10M(-114.8%) | $18.07M(-64.4%) | $21.10M(+112.6%) |
| Sep 2018 | - | $50.76M(-958.5%) | $9.93M(-119.1%) |
| Jun 2018 | - | -$5.91M(-85.9%) | -$51.96M(-51.0%) |
| Mar 2018 | - | -$41.82M(-706.6%) | -$106.03M(-25.6%) |
| Dec 2017 | -$142.54M(+1.0%) | $6.89M(-162.0%) | -$142.54M(-26.6%) |
| Sep 2017 | - | -$11.13M(-81.5%) | -$194.09M(-11.7%) |
| Jun 2017 | - | -$59.98M(-23.4%) | -$219.86M(+9.8%) |
| Mar 2017 | - | -$78.33M(+75.4%) | -$200.15M(+41.9%) |
| Dec 2016 | -$141.09M(+58.7%) | -$44.66M(+21.1%) | -$141.09M(+12.2%) |
| Sep 2016 | - | -$36.89M(-8.4%) | -$125.75M(+2.0%) |
| Jun 2016 | - | -$40.28M(+109.1%) | -$123.29M(+15.2%) |
| Mar 2016 | - | -$19.26M(-34.3%) | -$107.00M(+20.3%) |
| Dec 2015 | -$88.93M(+46.9%) | -$29.32M(-14.9%) | -$88.93M(+12.5%) |
| Sep 2015 | - | -$34.44M(+43.6%) | -$79.06M(+30.7%) |
| Jun 2015 | - | -$23.99M(+1912.3%) | -$60.50M(+21.3%) |
| Mar 2015 | - | -$1.19M(-93.9%) | -$49.89M(-17.6%) |
| Dec 2014 | -$60.54M(+31.4%) | -$19.44M(+22.5%) | -$60.54M(+17.0%) |
| Sep 2014 | - | -$15.88M(+18.6%) | -$51.74M(+10.1%) |
| Jun 2014 | - | -$13.38M(+13.0%) | -$47.00M(+2.5%) |
| Mar 2014 | - | -$11.84M(+11.3%) | -$45.86M(-0.5%) |
| Dec 2013 | -$46.09M(-1017.2%) | -$10.64M(-4.4%) | -$46.09M(+77.6%) |
| Sep 2013 | - | -$11.13M(-9.1%) | -$25.96M(+45.0%) |
| Jun 2013 | - | -$12.24M(+1.4%) | -$17.91M(+190.5%) |
| Mar 2013 | - | -$12.07M(-227.2%) | -$6.16M(-222.7%) |
| Dec 2012 | $5.03M(-86.6%) | $9.49M(-408.3%) | $5.03M(-260.3%) |
| Sep 2012 | - | -$3.08M(+514.4%) | -$3.13M(-110.0%) |
| Jun 2012 | - | -$501.00K(-43.5%) | $31.33M(-7.3%) |
| Mar 2012 | - | -$886.00K(-166.6%) | $33.80M(-10.0%) |
| Dec 2011 | $37.57M(-571.5%) | $1.33M(-95.8%) | $37.57M(-3.0%) |
| Sep 2011 | - | $31.38M(+1488.2%) | $38.73M(+262.7%) |
| Jun 2011 | - | $1.98M(-31.4%) | $10.68M(-22.9%) |
| Mar 2011 | - | $2.88M(+15.9%) | $13.85M(+493.1%) |
| Dec 2010 | -$7.97M | $2.49M(-25.4%) | $2.34M(-129.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $3.33M(-35.3%) | -$8.07M(-58.8%) |
| Jun 2010 | - | $5.15M(-159.7%) | -$19.58M(-51.1%) |
| Mar 2010 | - | -$8.64M(+9.1%) | -$40.01M(-21.6%) |
| Dec 2009 | -$51.04M(-42.4%) | -$7.92M(-3.2%) | -$51.04M(-29.1%) |
| Sep 2009 | - | -$8.18M(-46.5%) | -$71.98M(-11.7%) |
| Jun 2009 | - | -$15.28M(-22.3%) | -$81.51M(-6.5%) |
| Mar 2009 | - | -$19.66M(-31.8%) | -$87.20M(-1.6%) |
| Dec 2008 | -$88.61M(-57.3%) | -$28.85M(+62.9%) | -$88.61M(-52.8%) |
| Sep 2008 | - | -$17.71M(-15.5%) | -$187.73M(-4.8%) |
| Jun 2008 | - | -$20.97M(-0.5%) | -$197.26M(-2.7%) |
| Mar 2008 | - | -$21.08M(-83.5%) | -$202.66M(-2.2%) |
| Dec 2007 | -$207.30M(+93.4%) | -$127.97M(+369.8%) | -$207.30M(+120.4%) |
| Sep 2007 | - | -$27.24M(+3.3%) | -$94.04M(-11.2%) |
| Jun 2007 | - | -$26.36M(+2.5%) | -$105.94M(-1.0%) |
| Mar 2007 | - | -$25.72M(+74.8%) | -$107.02M(-0.2%) |
| Dec 2006 | -$107.20M(+383.1%) | -$14.71M(-62.4%) | -$107.20M(-7.9%) |
| Sep 2006 | - | -$39.14M(+42.6%) | -$116.40M(+127.8%) |
| Jun 2006 | - | -$27.45M(+6.0%) | -$51.11M(+74.7%) |
| Mar 2006 | - | -$25.90M(+8.3%) | -$29.26M(+31.9%) |
| Dec 2005 | -$22.19M(-51.5%) | -$23.91M(-191.4%) | -$22.19M(+17.4%) |
| Sep 2005 | - | $26.15M(-566.6%) | -$18.90M(-59.5%) |
| Jun 2005 | - | -$5.60M(-70.2%) | -$46.70M(-10.6%) |
| Mar 2005 | - | -$18.83M(-8.7%) | -$52.22M(+14.1%) |
| Dec 2004 | -$45.77M(+51.3%) | -$20.61M(+1151.7%) | -$45.77M(+108.4%) |
| Sep 2004 | - | -$1.65M(-85.2%) | -$21.96M(-27.2%) |
| Jun 2004 | - | -$11.13M(-10.1%) | -$30.15M(+3.1%) |
| Mar 2004 | - | -$12.38M(-487.7%) | -$29.25M(-3.3%) |
| Dec 2003 | -$30.26M(-68.0%) | $3.19M(-132.5%) | -$30.26M(-58.1%) |
| Sep 2003 | - | -$9.83M(-3.8%) | -$72.24M(-12.6%) |
| Jun 2003 | - | -$10.22M(-23.6%) | -$82.64M(-10.3%) |
| Mar 2003 | - | -$13.39M(-65.5%) | -$92.16M(-2.5%) |
| Dec 2002 | -$94.54M(+156.1%) | -$38.79M(+91.7%) | -$94.54M(+34.4%) |
| Sep 2002 | - | -$20.23M(+2.4%) | -$70.36M(+47.8%) |
| Jun 2002 | - | -$19.75M(+25.3%) | -$47.62M(+15.5%) |
| Mar 2002 | - | -$15.76M(+7.9%) | -$41.21M(+11.7%) |
| Dec 2001 | -$36.91M(+28.1%) | -$14.61M(-682.8%) | -$36.91M(+16.3%) |
| Sep 2001 | - | $2.51M(-118.8%) | -$31.73M(-25.1%) |
| Jun 2001 | - | -$13.34M(+16.4%) | -$42.38M(+23.8%) |
| Mar 2001 | - | -$11.46M(+21.5%) | -$34.22M(+18.8%) |
| Dec 2000 | -$28.81M(+71.5%) | -$9.43M(+16.0%) | -$28.81M(+24.9%) |
| Sep 2000 | - | -$8.13M(+56.7%) | -$23.07M(+19.3%) |
| Jun 2000 | - | -$5.19M(-14.1%) | -$19.34M(+3.2%) |
| Mar 2000 | - | -$6.05M(+63.4%) | -$18.75M(+11.6%) |
| Dec 1999 | -$16.80M(-16.0%) | -$3.70M(-15.9%) | -$16.80M(-15.6%) |
| Sep 1999 | - | -$4.40M(-4.3%) | -$19.90M(+2.1%) |
| Jun 1999 | - | -$4.60M(+12.2%) | -$19.50M(-14.8%) |
| Mar 1999 | - | -$4.10M(-39.7%) | -$22.90M(+14.5%) |
| Dec 1998 | -$20.00M(-492.2%) | -$6.80M(+70.0%) | -$20.00M(+51.5%) |
| Sep 1998 | - | -$4.00M(-50.0%) | -$13.20M(+57.1%) |
| Jun 1998 | - | -$8.00M(+566.7%) | -$8.40M(+2700.0%) |
| Mar 1998 | - | -$1.20M(<-9900.0%) | -$300.00K(-106.0%) |
| Dec 1997 | $5.10M(-13.6%) | $0.00(-100.0%) | $5.00M(-47.4%) |
| Sep 1997 | - | $800.00K(+700.0%) | $9.50M(+14.5%) |
| Jun 1997 | - | $100.00K(-97.6%) | $8.30M(-17.0%) |
| Mar 1997 | - | $4.10M(-8.9%) | $10.00M(+69.5%) |
| Dec 1996 | $5.90M | $4.50M(-1225.0%) | $5.90M(+321.4%) |
| Sep 1996 | - | -$400.00K(-122.2%) | $1.40M(-22.2%) |
| Jun 1996 | - | $1.80M | $1.80M |
FAQ
- What is Neurocrine Biosciences annual net profit?
- What is the all time high annual net income for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual net income year-on-year change?
- What is Neurocrine Biosciences quarterly net profit?
- What is the all time high quarterly net income for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly net income year-on-year change?
- What is Neurocrine Biosciences TTM net profit?
- What is the all time high TTM net income for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM net income year-on-year change?
What is Neurocrine Biosciences annual net profit?
The current annual net income of NBIX is $341.30M
What is the all time high annual net income for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual net profit is $407.30M
What is Neurocrine Biosciences annual net income year-on-year change?
Over the past year, NBIX annual net profit has changed by +$91.60M (+36.68%)
What is Neurocrine Biosciences quarterly net profit?
The current quarterly net income of NBIX is $103.10M
What is the all time high quarterly net income for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly net profit is $347.90M
What is Neurocrine Biosciences quarterly net income year-on-year change?
Over the past year, NBIX quarterly net profit has changed by +$59.70M (+137.56%)
What is Neurocrine Biosciences TTM net profit?
The current TTM net income of NBIX is $341.30M
What is the all time high TTM net income for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM net profit is $444.80M
What is Neurocrine Biosciences TTM net income year-on-year change?
Over the past year, NBIX TTM net profit has changed by -$28.40M (-7.68%)